---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-006493"
form_type: "8-K"
ticker: "SNDX"
cik: "0001395937"
company_name: "Syndax Pharmaceuticals Inc"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T04:42:23.976233+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director Fabrice Egros resigns from Syndax board; Dennis Podlesak joins Audit Committee

## Summary
- Fabrice Egros resigned from Syndax board effective Feb 23, 2022 due to expanded role at Lupin Limited.
- Resignation not due to any disagreement with the company on operations, policies, or practices.
- Board appointed Dennis G. Podlesak to the Audit Committee following Egros' departure.

## SEC filing metadata
- accession: 0001564590-22-006493
- form_type: 8-K
- ticker: SNDX
- cik: 0001395937
- company_name: Syndax Pharmaceuticals Inc
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1395937/000156459022006493/0001564590-22-006493-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1395937/000156459022006493/sndx-8k_20220222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-006493
- JSON: https://secwatch.observer/filing/0001564590-22-006493.json
- Plain text: https://secwatch.observer/filing/0001564590-22-006493.txt

## Key facts
- Executive change
  Fabrice Egros resigned as Director at Syndax Pharmaceuticals Inc.
  - Action: resigned
  - Role: Director
  source text: On February 22, 2022, Fabrice Egros, PharmD, Ph.D. notified Syndax Pharmaceuticals, Inc. (the "Company") of his decision to resign from the Board of Directors of the Company (the "Board") due to an increase in the scope of his role at Lupin Limited.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1395937/000156459022006493/0001564590-22-006493-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.